Jane Street Group, LLC Allogene Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $384 Billion
  • Q1 2025

A detailed history of Jane Street Group, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 1,116,681 shares of ALLO stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,116,681
Previous 1,116,681 -0.0%
Holding current value
$1.3 Million
Previous $1.63 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$1.4 - $2.84 $1.33 Million - $2.7 Million
952,158 Added 578.74%
1,116,681 $1.63 Million
Q4 2024

Feb 14, 2025
SELL
$1.84 - $3.22 $502,684 - $879,697
-273,198 Reduced 62.41%
164,523 $350,000
Q3 2024

Nov 14, 2024
SELL
$2.08 - $3.5 $348,225 - $585,956
-167,416 Reduced 27.67%
437,721 $1.23 Million
Q2 2024

Aug 14, 2024
BUY
$2.23 - $4.38 $1.13 Million - $2.22 Million
507,464 Added 519.55%
605,137 $1.41 Million
Q1 2024

May 15, 2024
SELL
$2.92 - $5.63 $757,027 - $1.46 Million
-259,256 Reduced 72.64%
97,673 $436,000
Q4 2023

Feb 14, 2024
BUY
$2.28 - $3.5 $753,029 - $1.16 Million
330,276 Added 1239.17%
356,929 $1.15 Million
Q3 2023

Nov 14, 2023
SELL
$3.17 - $5.96 $273,412 - $514,050
-86,250 Reduced 76.39%
26,653 $84,000
Q2 2023

Aug 14, 2023
BUY
$4.53 - $6.74 $237,834 - $353,863
52,502 Added 86.92%
112,903 $561,000
Q1 2023

May 15, 2023
BUY
$4.92 - $8.21 $247,510 - $413,020
50,307 Added 498.39%
60,401 $298,000
Q4 2022

Feb 14, 2023
SELL
$5.62 - $11.11 $870,611 - $1.72 Million
-154,913 Reduced 93.88%
10,094 $63,000
Q3 2022

Nov 14, 2022
BUY
$10.32 - $17.28 $832,885 - $1.39 Million
80,706 Added 95.74%
165,007 $1.78 Million
Q2 2022

Aug 16, 2022
BUY
$6.78 - $12.28 $379,246 - $686,894
55,936 Added 197.2%
84,301 $961,000
Q1 2022

May 17, 2022
SELL
$7.65 - $15.29 $296,422 - $592,456
-38,748 Reduced 57.74%
28,365 $259,000
Q4 2021

Feb 15, 2022
BUY
$13.13 - $24.52 $679,595 - $1.27 Million
51,759 Added 337.1%
67,113 $1 Million
Q3 2021

Nov 16, 2021
BUY
$21.01 - $27.64 $72,673 - $95,606
3,459 Added 29.08%
15,354 $395,000
Q1 2021

May 18, 2021
SELL
$25.79 - $39.02 $463,265 - $700,916
-17,963 Reduced 60.16%
11,895 $420,000
Q4 2020

Feb 17, 2021
SELL
$25.24 - $43.45 $3,003 - $5,170
-119 Reduced 0.4%
29,858 $753,000
Q3 2020

Nov 17, 2020
BUY
$32.38 - $44.96 $287,275 - $398,885
8,872 Added 42.04%
29,977 $1.13 Million
Q2 2020

Aug 17, 2020
BUY
$18.39 - $54.04 $388,120 - $1.14 Million
21,105 New
21,105 $904,000
Q4 2019

Feb 14, 2020
SELL
$24.82 - $31.4 $677,461 - $857,063
-27,295 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$26.11 - $32.99 $712,672 - $900,462
27,295 New
27,295 $744,000

Others Institutions Holding ALLO

# of Institutions
176
Shares Held
165M
Call Options Held
202K
Put Options Held
76.6K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $167M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email